Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial.
Pawlak D, Rangger C, Kolenc Peitl P, Garnuszek P, Maurin M, Ihli L, Kroselj M, Maina T, Maecke H, Erba P, Kremser L, Hubalewska-Dydejczyk A, Mikołajczak R, Decristoforo C. Pawlak D, et al. Eur J Pharm Sci. 2016 Mar 31;85:1-9. doi: 10.1016/j.ejps.2016.01.023. Epub 2016 Jan 27. Eur J Pharm Sci. 2016. PMID: 26826279 Free PMC article.
99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience.
Hubalewska-Dydejczyk A, Fröss-Baron K, Mikołajczak R, Maecke HR, Huszno B, Pach D, Sowa-Staszczak A, Janota B, Szybiński P, Kulig J. Hubalewska-Dydejczyk A, et al. Eur J Nucl Med Mol Imaging. 2006 Oct;33(10):1123-33. doi: 10.1007/s00259-006-0113-7. Epub 2006 May 24. Eur J Nucl Med Mol Imaging. 2006. PMID: 16721571
99mTc-EDDA/HYNIC-octreotate in detection of atypical bronchial carcinoid.
Hubalewska-Dydejczyk A, Fröss-Baron K, Gołkowski F, Sowa-Staszczak A, Mikołajczak R, Huszno B. Hubalewska-Dydejczyk A, et al. Exp Clin Endocrinol Diabetes. 2007 Jan;115(1):47-9. doi: 10.1055/s-2007-948311. Exp Clin Endocrinol Diabetes. 2007. PMID: 17286235
Radio-guided surgery with the use of [99mTc-EDDA/HYNIC]octreotate in intra-operative detection of neuroendocrine tumours of the gastrointestinal tract.
Hubalewska-Dydejczyk A, Kulig J, Szybinski P, Mikolajczak R, Pach D, Sowa-Staszczak A, Fröss-Baron K, Huszno B. Hubalewska-Dydejczyk A, et al. Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1545-55. doi: 10.1007/s00259-007-0476-4. Epub 2007 Jul 25. Eur J Nucl Med Mol Imaging. 2007. PMID: 17653543 Clinical Trial.
New forms of radionuclide therapy with (90)Y in oncology.
Hubalewska-Dydejczyk A, Jurczak W, Sowa-Staszczak A, Kunikowska J, Królicki L, Gilis-Januszewska A, Giza A, Szurkowska M, Pach D, Głowa B, Mikołajczak R, Pawlak D, Stefańska A, Huszno B, Skotnicki AB. Hubalewska-Dydejczyk A, et al. Nucl Med Rev Cent East Eur. 2008;11(1):5-11. Nucl Med Rev Cent East Eur. 2008. PMID: 19173181 Clinical Trial.
Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs).
Sowa-Staszczak A, Pach D, Chrzan R, Trofimiuk M, Stefańska A, Tomaszuk M, Kołodziej M, Mikołajczak R, Pawlak D, Hubalewska-Dydejczyk A. Sowa-Staszczak A, et al. Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1669-74. doi: 10.1007/s00259-011-1835-8. Epub 2011 May 11. Eur J Nucl Med Mol Imaging. 2011. PMID: 21559978 Free PMC article. Clinical Trial.
Repeated cycles of peptide receptor radionuclide therapy (PRRT)--results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET.
Pach D, Sowa-Staszczak A, Kunikowska J, Królicki L, Trofimiuk M, Stefańska A, Tomaszuk M, Głowa B, Mikołajczak R, Pawlak D, Jabrocka-Hybel A, Hubalewska-Dydejczyk AB. Pach D, et al. Radiother Oncol. 2012 Jan;102(1):45-50. doi: 10.1016/j.radonc.2011.08.006. Epub 2011 Aug 30. Radiother Oncol. 2012. PMID: 21885142
256 results